Aeras invites SSI to collaborate on vaccine development  

The international research fund sponsored by Bill Gates has invited the State Serum Institute to collaborate on developing a new TB vaccine

The international research fund Aeras has invited the State Serum Institute (SSI) to collaborate on development and testing of a new TB vaccine. Aeras is a non-profit organisation which recently received a DKK 500 million (USD 80 million) donation from Melinda and Bill Gates Foundation for the purpose of developing a TB vaccine, a research area which big pharma does not see as lucrative to invest in.


Jearald Sadoff, CEO of Aeras who visited Denmark last week says SSI perhaps has the world's leading research group in the development of a new TB vaccine with a very exciting technology. He hopes to agree on a collaboration so that a future vaccine will be Danish produced by SSI. Aeros is prepared to invest a considerable sum in Denmark for development and clinical trials, and according to the CEO it will be natural to place factories for vaccine production in Denmark when the vaccine is completed.


Head of research at SSI Peter Andersen, says they are prepared to collaborate with Aeras and that SSI is very proud of the international acknowledgement. He is sure that an agreement can accelerate the development of a new TB vaccine in the very costly phase the work is entering.


Around 2 million people die each year because of TB. The disease is a particular scourge in developing countries. Aeras aims to make the vaccines as cheap as possible to encourage greatest use. The news is reported by financial newspaper Børsen online, BiotechDenmark online and on SSI's website.


Link > State Serum Institute 

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×